Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma.
Lian B, Li Z, Wu N, Li M, Chen X, Zheng H, Gao M, Wang D, Sheng X, Tian H, Si L, Chi Z, Wang X, Lai Y, Sun T, Zhang Q, Kong Y, Long GV, Guo J, Cui C.
Lian B, et al. Among authors: guo j.
Ann Oncol. 2024 Feb;35(2):211-220. doi: 10.1016/j.annonc.2023.10.793. Epub 2023 Nov 11.
Ann Oncol. 2024.
PMID: 37956739
Free article.
Clinical Trial.